|Description||Cholinesterase deficiency will result in prolonged paralysis after the use of muscle relaxants for operative surgery. Please contact Clinical Biochemistry if this assay is required.|
|Indication||Scoline apnoea. Family studies of patients with cholinesterase deficiency. Pesticide workers.
|Additional Info||Cholinesterase phenotype is used to predict susceptibility to prolonged apnoea after administration of suxamethonium or mivacurium.|
|Department||* Not Specified *|
|Collection Conditions||Samples should not be collected less than 12 hours after the administration of suxamethonium or mivacurium. If patient has been treated with with fresh frozen plasma or a cholinesterase preparation a period of at least 6 weeks should be allowed before a sample is collected.|
|Min. Vol||1 mL|
|Ref. Range (Male)||See notes|
|Ref. Range (Female)||see notes|
|Ref. Range (Paed)|| |
|Ref. Range Notes||Cholinesterase activity ref range: <5300 U/L|
|IP Acute TAT||About 2 weeks|
|IP Routine TAT||About 2 weeks|
|GP Acute TAT||About 2 weeks|
|GP Routine TAT||About 2 weeks|
|Turnround Comment||Activity: 1-2 weeks (contact referral lab if surgery is imminent). Phenotype: 2-4 weeks. Genotype: 10-12 weeks. Dr Roberta Goodall:firstname.lastname@example.org|
Originally edited by : JHB. Review due on 22/11/2018 10:16:43. Published By RB on 22/11/2017 10:16:43.